A detailed history of Pallas Capital Advisors LLC transactions in Natera, Inc. stock. As of the latest transaction made, Pallas Capital Advisors LLC holds 6,469 shares of NTRA stock, worth $992,473. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,469
Previous 4,209 53.69%
Holding current value
$992,473
Previous $455,000 80.66%
% of portfolio
0.03%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024

BUY
$97.75 - $129.67 $220,915 - $293,054
2,260 Added 53.69%
6,469 $822,000
Q2 2024

Jul 19, 2024

BUY
$85.28 - $112.6 $358,943 - $473,933
4,209 New
4,209 $455,000

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $14.9B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Pallas Capital Advisors LLC Portfolio

Follow Pallas Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pallas Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pallas Capital Advisors LLC with notifications on news.